Domingo-Marques Sandra, Nieto-García Eduardo, Fernández-Erhling Nadia, Ramírez-Andrés Leonor, Vicente-Mampel Juan, Ferrer-Torregrosa Javier
Podiatry Department, Faculty of Medicine and Health Sciences, Valencia Catholic University San Vicente Mártir, 46001 Valencia, Spain.
Department of Physiotherapy, School of Medicine and Health Science, Catholic University of Valencia, Torrent, 46001 Valencia, Spain.
J Clin Med. 2025 Apr 20;14(8):2843. doi: 10.3390/jcm14082843.
Chronic plantar fasciopathy is a degenerative pathology that elicits persistent heel pain, significantly impacting quality of life. When conservative treatments fail to yield satisfactory outcomes, radiofrequency microtenotomy utilizing the Topaz technique presents a minimally invasive alternative with regenerative potential. This study aims to evaluate its efficacy in pain reduction, functional improvement, and complication rate compared to other treatments. A systematic review was conducted in accordance with the PRISMA guidelines and registered in PROSPERO (CRD4202525648314). PubMed, EBSCOhost, Web of Science, and Scopus (2014-2024) were comprehensively searched to identify studies on the Topaz technique for refractory chronic plantar fasciopathy. Clinical trials, cohort studies, and case series were included, and a meta-analysis was performed using a random-effects model to assess pain, the Visual Analog Scale (VAS), American Orthopaedic Foot & Ankle Society function(AOFAS), and complications. Fifteen studies encompassing 1576 patients were analyzed. The meta-analysis demonstrated a significant reduction in pain of 5.90 points on the VAS scale (95% CI: 5.03 to 6.77, < 0.001) and a functional improvement of 0.28 points on the AOFAS scale (95% CI: 0.27 to 0.28, < 0.001). The complication rate was low (3.00%), with high patient satisfaction (90%) and rapid recovery. The findings suggest that the Topaz technique is a safe and effective option for chronic plantar fasciopathy, demonstrating significant improvements and minimal complications.
慢性足底筋膜炎是一种退行性病变,会引发持续的足跟疼痛,严重影响生活质量。当保守治疗未能取得满意效果时,采用托帕斯技术的射频微切开术提供了一种具有再生潜力的微创替代方案。本研究旨在评估其与其他治疗方法相比在减轻疼痛、改善功能和并发症发生率方面的疗效。根据PRISMA指南进行了系统评价,并在PROSPERO(CRD4202525648314)中注册。全面检索了PubMed、EBSCOhost、Web of Science和Scopus(2014 - 2024年),以识别关于托帕斯技术治疗难治性慢性足底筋膜炎的研究。纳入了临床试验、队列研究和病例系列,并使用随机效应模型进行荟萃分析,以评估疼痛、视觉模拟量表(VAS)、美国矫形足踝协会功能评分(AOFAS)和并发症。分析了15项研究,共1576例患者。荟萃分析表明,VAS量表上疼痛显著减轻5.90分(95%CI:5.03至6.77,P<0.001),AOFAS量表上功能改善0.28分(95%CI:0.27至0.28,P<0.001)。并发症发生率较低(3.00%),患者满意度高(90%)且恢复迅速。研究结果表明,托帕斯技术是治疗慢性足底筋膜炎的一种安全有效的选择,具有显著改善且并发症极少。